← Beclomethasone Dipropionate Inhaler

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Beclomethasone Dipropionate Inhaler

Corticosteroid

Prepared 24 Sep 2026

What it is used for

Prevention of bronchial asthma (not for acute attack) not well controlled by the bronchodilators Clinical selection for Beclomethasone Dipropionate Inhaler should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Corticosteroid. Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Active pulmonary TB; airways obstruction; times of stress; gradual withdrawal of systematic steroid therapy; respiratory infections; not to be withdrawn suddenly

Possible side effects

Throat candidiasis; hoarseness of the voice; throat irritation; paradoxical bronchospasm [discontinue]; adrenal suppression; cataract formation after prolonged use; cutaneous hypersensitivity

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage